title: Oocyte-derived growth factors and ovulation rate in sheep.
abstract: The physiological mechanisms controlling ovulation rate in mammals involve a complex exchange of endocrine signals between the pituitary gland and the ovary, and a localized exchange of intraovarian hormones between the oocyte and its adjacent somatic cells. The discoveries in sheep of mutations in bone morphogenetic protein 15 (BMP15) and bone morphogenetic protein receptor type IB (BMPR-IB) together with recent findings on the physiological effects of growth differentiation factor 9 (GDF9) and BMP15 on follicular development and ovulation rate highlight some important differences in the way in which the oocyte may function in mammals with different ovulation rate phenotypes. In sheep, BMP15 and GDF9 have each been shown to be essential for the early and later stages of follicular development. In addition, ovulation rate is sensitive to changes in the dose of either of these two oocyte-derived growth factors. These findings are in contrast to those reported for mice in which GDF9, but not BMP15, is essential for follicular development. The evidence to date is consistent with the hypothesis that the oocyte plays a central role in regulating key events in the process of follicular development and hence, is important in determining ovulation rate. Moreover, it appears that the mechanisms that the oocyte uses to control these processes differ between species with low and high ovulation rate phenotypes.
authors.affiliation: AgResearch, Wallaceville Animal Research Centre, PO Box 40063, Upper Hutt, New Zealand. kenneth.mcnatty@agresearch.co.nz
authors.forename: K P
authors.initials: KP
authors.lastname: McNatty
authors.forename: J L
authors.initials: JL
authors.lastname: Juengel
authors.forename: T
authors.initials: T
authors.lastname: Wilson
authors.forename: S M
authors.initials: SM
authors.lastname: Galloway
authors.forename: G H
authors.initials: GH
authors.lastname: Davis
authors.forename: N L
authors.initials: NL
authors.lastname: Hudson
authors.forename: C L
authors.initials: CL
authors.lastname: Moeller
authors.forename: M
authors.initials: M
authors.lastname: Cranfield
authors.forename: K L
authors.initials: KL
authors.lastname: Reader
authors.forename: M P E
authors.initials: MP
authors.lastname: Laitinen
authors.forename: N P
authors.initials: NP
authors.lastname: Groome
authors.forename: H R
authors.initials: HR
authors.lastname: Sawyer
authors.forename: O
authors.initials: O
authors.lastname: Ritvos
mesh_terms: D000818:Animals; D055430:Bone Morphogenetic Protein 15; D052005:Bone Morphogenetic Protein Receptors, Type I; D019485:Bone Morphogenetic Proteins / Q000235:genetics*; D005260:Female; D055429:Growth Differentiation Factor 9; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics; D009154:Mutation; D009865:Oocytes / Q000502:physiology*; D006080:Ovarian Follicle / Q000502:physiology; D010060:Ovulation / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D017978:Receptors, Growth Factor / Q000235:genetics; D012756:Sheep / Q000502:physiology*
chemical_list: C525902:Bmp15 protein, mouse; D055430:Bone Morphogenetic Protein 15; D019485:Bone Morphogenetic Proteins; C525898:Gdf9 protein, mouse; D055429:Growth Differentiation Factor 9; D036341:Intercellular Signaling Peptides and Proteins; D017978:Receptors, Growth Factor; D017346:Protein Serine-Threonine Kinases; D052005:Bone Morphogenetic Protein Receptors, Type I